This text is a result of machine translation.
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%
BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
Hong Kong stocks continued to rise in the anti epidemic sector, and Junshi biology rose nearly 17%
RNA Biotech Therorna Bags Over CNY 280 Mn in Series A Financing Round
Therorna, specialized in the development of cutting-edge circular RNA technology-based vaccines and therapies, will accelerate the development of a new broad-spectrum COVID-19 vaccine and other product pipelines with the fresh proceeds.
Jun 23, 2022 03:45 PM
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Updated 3 hours ago
Successful Multinational Corporations in China Series: Qualcomm China
Jun 25, 2022 02:02 PM